Glass Medicine Bottles Market Share, Size, Trends, Industry Analysis Report, By Glass Type (Type I (Borosilicate glass / Neutral glass), Type II (soda-lime-silica glass), Type III (Regular soda-lime glass), Type IV (Type NP glass)), By Filament Type, By Medicine Type, By Region; Segment Forecast, 2023-2032
The global glass medicine bottles market size is expected to reach USD 28.32 billion by 2032, according to a new study by Polaris Market Research. The report “Glass Medicine Bottles Market Share, Size, Trends, Industry Analysis Report, By Glass Type (Type I (Borosilicate glass / Neutral glass), Type II (soda-lime-silica glass), Type III (Regular soda-lime glass), Type IV (Type NP glass)), By Filament Type, By Medicine, By Region; Segment Forecast, 2023-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Spur in innovation in the glass medicine bottles is gaining huge popularity in the pharmaceutical sector. Various industry participants largely contribute to the market by expanding their product portfolio with the latest technologies. Advancements in glass manufacturing technologies have led to innovative designs, such as child-resistant caps, tamper-evident features, and improved drug delivery systems. For example, in April 2021, Chicco introduced a revolutionary innovation combining plastic and glass's strength and purity in one amazing container.
A premium plastic exterior layer is attached to two ultra-thin inner layers of 100% pure Invinci-glass to create the ChiccoDUO baby bottle. This cutting-edge, proprietary manufacturing process is also used to develop medical and pharmaceutical products. These advancements contribute to the growth of the glass medicine bottle market by offering enhanced functionality and convenience. Such various innovations have led many businesses to invest in the latest technologies and help they need to improve global revenue.
The growing global population has increased the prevalence of chronic diseases. For example, as per the Centers for Disease Control and Prevention, in the U.S., 6 in 10 adults have chronic conditions. It is driving the demand for pharmaceutical products. It, in turn, fuels the demand for glass medicine bottles as a primary packaging solution. Furthermore, regulatory authorities impose strict guidelines for the packaging and storage of pharmaceutical products to ensure patient safety. Glass containers often meet these regulatory requirements due to their chemical inertness, impermeability, and ability to withstand sterilization processes.
Glass Medicine Bottles Market Report Highlights
Type I glass type accounted for a larger global revenue market share in the fiscal year 2022. It is due to the preferred choice for medicine bottles in the pharmaceutical industry
Tubular filament glass is expected to grow at the fastest CAGR during the forecast period due to its durability, chemical resistance, and recyclability.
Generic medicine type is expected to account for a major share in the global market due to huge use in pharmaceutical with their ability to protect the integrity of the medication.
North America held the largest global market share by the end of 2022 due to expanding pharmaceutical sector and innovations.
The global players include Ardagh Group, AGI Glaspac, Ajanta Bottle, Beatson Clark, Bonpak, Shandong Province Medicinal Glass, PGP Glass, Gerresheimer, SENCO Pharma Packaging, Stoelzle Glass Group.
Polaris Market Research has segmented the Glass Medicine Bottles market report based on glass type, filament type, medicine type, and region:
Glass Medicine Bottles, Glass Type Outlook (Revenue - USD Billion, 2019-2032)
Type I (Borosilicate glass / Neutral glass)
Type II (soda-lime-silica glass)
Type III (Regular soda-lime glass)
Type IV (Type NP glass)
Glass Medicine Bottles, Filament Type Outlook (Revenue - USD Billion, 2019-2032)
Molded
Tubular
Glass Medicine Bottles, Medicine Type Outlook (Revenue - USD Billion, 2019-2032)
Generic
Branded
Biological
Ayurveda
Herbal
Glass Medicine Bottles, Regional Outlook (Revenue - USD Billion, 2019-2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa